Connor, Clark & Lunn Investment Management Ltd.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1596800
VANCOUVER, A1
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$67,175,777
-$45,223,252 QoQ
Shares Held
135,236
-46.3% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#148
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. VRTX ranks #1 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,175,777 | 135,236 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $112,399,029 | 251,711 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $156,582,836 | 345,383 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $86,474,503 | 220,801 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $91,753,494 | 206,095 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,394,959 | 15,253 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,457,908 | 21,003 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,642,041 | 7,831 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $31,584,697 | 67,385 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $49,928,786 | 119,444 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $27,831,276 | 68,400 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,772,430 | 5,097 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,372,449 | 3,900 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,597,404 | 5,070 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,224,517 | 11,166 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,233,069 | 28,435 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $16,823,144 | 59,701 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,878,162 | 30,188 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,882,366 | 22,233 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,481,965 | 24,709 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,720,476 | 18,452 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,764,970 | 22,174 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,023,833 | 25,488 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,491,750 | 53,255 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $26,607,201 | 91,651 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $23,097,330 | 97,068 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||